Ear Wax Relief
Ear Wax Relief
Approved
Approval ID
1b548338-f9f0-4a63-b553-df4fcd18d594
Product Type
HUMAN OTC DRUG LABEL
Effective Date
Apr 10, 2025
Manufacturers
FDA
Similasan Corporation
DUNS: 111566530
Products 1
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
causticum, graphite, lachesis muta venom and lycopodium clavatum spore
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
NDC Product Code59262-272
Product Classification
G
Generic Name
causticum, graphite, lachesis muta venom and lycopodium clavatum spore
Product Specifications
Route of AdministrationAURICULAR (OTIC)
Effective DateApril 10, 2025
FDA Product Classification
INGREDIENTS (5)
GLYCERINInactive
Code: PDC6A3C0OX
Classification: IACT
CAUSTICUMActive
Quantity: 12 [hp_X] in 10 mL
Code: DD5FO1WKFU
Classification: ACTIB
LYCOPODIUM CLAVATUM SPOREActive
Quantity: 12 [hp_X] in 10 mL
Code: C88X29Y479
Classification: ACTIB
LACHESIS MUTA VENOMActive
Quantity: 12 [hp_X] in 10 mL
Code: VSW71SS07I
Classification: ACTIB
GRAPHITEActive
Quantity: 15 [hp_X] in 10 mL
Code: 4QQN74LH4O
Classification: ACTIB